Interleukin-26 in airway morbidities of long-term tobacco smokers
K. Che (Stockholm, Sweden), E. Tufvesson (Lund, Sweden), S. Tengvall (Gothenburg, Sweden), E. Lappi-Blanco (Oulu, Finland), R. Kaarteenaho (Oulu, Finland), B. Levanen (Stockholm, Sweden), M. Ekberg (Lund, Sweden), A. Brauner (Stockholm, Sweden), å. Wheelock (Stockholm, Sweden), L. Bjermer (Lund, Sweden), M. SköLd (Stockholm, Sweden), A. LindéN (Stockholm, Sweden)
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Che (Stockholm, Sweden), E. Tufvesson (Lund, Sweden), S. Tengvall (Gothenburg, Sweden), E. Lappi-Blanco (Oulu, Finland), R. Kaarteenaho (Oulu, Finland), B. Levanen (Stockholm, Sweden), M. Ekberg (Lund, Sweden), A. Brauner (Stockholm, Sweden), å. Wheelock (Stockholm, Sweden), L. Bjermer (Lund, Sweden), M. SköLd (Stockholm, Sweden), A. LindéN (Stockholm, Sweden). Interleukin-26 in airway morbidities of long-term tobacco smokers. 5480
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: